ArticleTranslational cancer research2026
Multi-omics clustering combined with multiple machine learning to identify epigenetic features in low-grade glioma patients.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Epigenetic heterogeneity has been demonstrated in a wide range of cancers including leukemia, colorectal cancer, and glioma; in the case of low-grade glioma (LGG), its association with tumor malignant progression and immune microenvironmental regulation has been less reported. This study aimed to further explore the application of epigenetics in LGG. Methods: Epigenetic subtypes were identified based on consensus clustering of multi-omics data, and prognostic models were constructed based on 101 machine learning combinations. Biological differences among different risk groups were explored by functional enrichment analysis, and finally Jumonji Domain-Containing 8 ( Results: We revealed three epigenetic molecular subtypes in LGG patients, and the chromosomal regulator-associated risk score, defined as an independent prognostic factor for LGGs, was effective in predicting the response to treatment in LGG patients. Conclusions: This study reveals the molecular pattern and prognostic model of epigenetic inheritance in LGG, and the key gene
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.